Solid Biosciences Provides Update Regarding the IGNITE DMD Phase I/II Clinical Hold
Tonight at PPMD’s Virtual Annual Conference, Solid Biosciences shared that their IGNITE DMD Phase I/II clinical trial will remain on clinical hold. They also issued a press release here. During this hold, Solid will continue to…Learn More